


Eureka Biotechnology Limited
Biotechnology Research • Nanshan District, Guangdong, China • 1-10 Employees
Company overview
| Headquarters | 5/F, Zone B, TCL Tech Bldg,, No. 1055 Nanhai St., Nanshan,, Shenzhen, Guangdong, CN |
| Phone number | +8675586562586 |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Eureka Biotechnology Limited
Peter Rezk
Business Development Director
About Eureka Biotechnology Limited
Eurekabio stands as a pioneering force in the realm of cell and gene therapy, serving as a leading upstream core supplier.Our primary focus lies in the research and development of pivotal biotechnology and autonomous equipment in the field of gene and cell therapy (CGT). By seamlessly integrating automation technology, artificial intelligence, and diverse disciplines with biotechnology, we have successfully addressed crucial technological challenges in gene therapy, cell therapy, life science, and pharmaceutical R&D. Through the synergies of cross-disciplinary collaboration and technological innovation, Eurekabio has consistently pushed the boundaries of therapy.Eurekabio has brought forth advanced cellular drug production solutions and the EuLV lentiviral vector platform. These breakthroughs, including high-titer stable lentiviral vector packaging and producer cell lines, are poised to play a pivotal role in the global commercialization of CGT drugs. Our ultimate aim is to bring tangible benefits to patients worldwide by ushering in a new era of advanced and accessible therapies.
Eureka Biotechnology Limited revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | $41,700,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Explore Eureka Biotechnology Limited's funding history, including investment rounds, total capital raised, and key backers.
Frequently asked questions
4.8
40,000 users



